FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Naga Chalasani

Research Profile

Disorders

Anatomy

Livers

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Howard C Masuoka; Naga Chalasani
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.
Sara K Quinney; Raj Vuppalanchi; Naga Chalasani; Gorski Jan; Mitchell A Hamman; Srikar R Malireddy; Stephen D Hall
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.
Naga Chalasani
Reply.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Naga Chalasani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Howard C Masuoka; Naga Chalasani
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.
Annals of the New York Academy of Sciences 2013;1281():106-22.
2013: Sara K Quinney; Raj Vuppalanchi; Naga Chalasani; Gorski Jan; Mitchell A Hamman; Srikar R Malireddy; Stephen D Hall
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.
European journal of clinical pharmacology 2013;69(3):439-48.
2013: Naga Chalasani
Reply.
Hepatology (Baltimore, Md.) 2013;57(2):853-4.
2012: Thomas J Urban; Paul B Watkins; Guruprasad P Aithal; Herbert Bonkovsky; Naga Chalasani; Ann K Daly; Timothy J Davern; Aris Floratos; Robert J Fontana; Dongliang Ge; David B Goldstein; William M Lee; M Isabel Lucena; Mariam Molokhia; Victor J Navarro; Matthew R Nelson; Itsik Pe'er; James Rochon; Jose Serrano; Yufeng Shen; Kevin V Shianna; Andrew Stolz; Jayant A Talwalkar
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
Pharmacogenetics and genomics 2012;22(11):784-95.
2012: Julia Wattacheril; Naga Chalasani
Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition?
Hepatology (Baltimore, Md.) 2012;56(4):1580-4.
2012: Hemant Chatrath; Marwan Ghabril; Suthat Liangpunsakul; Julie Otte; Naga Chalasani; Raj Vuppalanchi
Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.
The American journal of medicine 2012;125(10):1019-25.
2012: Lauren N Bell; Elizabeth M Brunt; Naga Chalasani; Sadhana Chalasani; Anna Mae Diehl; Allison M Fullenkamp; Kris V Kowdley; Arthur J McCullough; Sriya Muralidharan; Brent A Neuschwander-Tetri; Arun J Sanyal; Aynur Unalp; Jiangxia Wang; Laura A Wilson; Nathan M Bass
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
Hepatology (Baltimore, Md.) 2012;56(4):1311-8.
2012: Suthat Liangpunsakul; Naga Chalasani
What should we recommend to our patients with NAFLD regarding alcohol use?
The American journal of gastroenterology 2012;107(7):976-8.
2012: Naga Chalasani; Robert J Fontana; Huiman Barnhart; Herbert Bonkovsky; David E Kleiner; Victor Navarro; Raj Vuppalanchi; Jay H Hoofnagle
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
Annals of internal medicine 2012;156(12):857-60, W297-300.
2012: Naga Chalasani; Michael Charlton; Kenneth Cusi; Anna Mae Diehl; Joel E Lavine; Arun J Sanyal; Zobair Younossi; Elizabeth M Brunt
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
Gastroenterology 2012;142(7):1592-609.
2012: Naga Chalasani; Michael Charlton; Kenneth Cusi; Anna Mae Diehl; Joel E Lavine; Arun J Sanyal; Zobair Younossi; Elizabeth M Brunt
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
The American journal of gastroenterology 2012;107(6):811-26.
2012: Naga Chalasani; Michael Charlton; Kenneth Cusi; Anna Mae Diehl; Joel E Lavine; Elizabeth M Brunt; Zobair Younossi; Arun J Sanyal
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
Hepatology (Baltimore, Md.) 2012;55(6):2005-23.
2012: L N Bell; H L Bonkovsky; Naga Chalasani; Robert J Fontana; J Rochon; J Serrano; Raj Vuppalanchi; M Wang; P B Watkins
Serum proteomic profiling in patients with drug-induced liver injury.
Alimentary pharmacology & therapeutics 2012;35(5):600-12.
2012: Hemant Chatrath; Raj Vuppalanchi; Naga Chalasani
Dyslipidemia in patients with nonalcoholic fatty liver disease.
Seminars in liver disease 2012;32(1):22-9.
2012: Vlad Ratziu; Christophe Renou; Franck S Rousseau; Arun J Sanyal; Muhammad Y Sheikh; Manal Abdelmalek; Anezi Bakken; B Raj Bhandari; Naga Chalasani; Hari S Conjeevaram; Melanie Cornpropst; Benjamin King; Robert A Levine; Wei Liang; Joseph K Lim; John McHutchison; Elsa Mondou; Melissa Palmer; Mario Chojkier
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2012;55(2):419-28.
2012: Tohti Amet; Daniel Byrd; Naga Chalasani; Marwan Ghabril; Ayslinn Grantham; Johnny J He; Ningjie Hu; Ziqing Liu; Xuebin Qin; Qigui Yu
CD59 incorporation protects hepatitis C virus against complement-mediated destruction.
Hepatology (Baltimore, Md.) 2012;55(2):354-63.
2012: Rongrong Wei; Fan Yang; Thomas J Urban; Naga Chalasani; David A Flockhart; Lang Li; Wanqing Liu
Impact of the Interaction between 3'-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes.
Frontiers in genetics 2012;3():248.
2012: Kris V Kowdley; James E Nelson; Brent A Neuschwander-Tetri; Arun J Sanyal; Laura A Wilson; Matthew M Yeh; Patricia Belt; Naga Chalasani
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2012;55(1):77-85.
2011: Kathleen E Corey; Naga Chalasani
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
Hepatology (Baltimore, Md.) 2011;54(5):1503-5.
2011: Timothy J Davern; Suzanne U Emerson; Ronald E Engle; Robert J Fontana; Jiezhun Gu; Paul H Hayashi; Jay H Hoofnagle; David E Kleiner; Hanh Nguyen; Petr Protiva; Robert H Purcell; Jose Serrano; Hans L Tillmann; Naga Chalasani
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.
Gastroenterology 2011;141(5):1665-72.e1-9.
2011: Raj Vuppalanchi; David Agarwal; Lauren N Bell; Marwan Ghabril; Matthew S Johnson; Ravi Juluri; Lisa Kamendulis; James E Klaunig; Romil Saxena; Naga Chalasani
Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements.
The American journal of the medical sciences 2011;342(4):314-7.
2011: Lauren N Bell; Ann Klipsch; Jean P Molleston; Michael J Morton; Romil Saxena; Raj Vuppalanchi; Naga Chalasani
Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.
Journal of clinical gastroenterology 2011;45(9):800-7.
2011: Sweta Tandra; Aynur Unalp; Raj Vuppalanchi; Laura A Wilson; Matthew M Yeh; Elizabeth M Brunt; Naga Chalasani; Oscar W Cummings
Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
Journal of hepatology 2011;55(3):654-9.
2011: Jean P Molleston; Naga Chalasani; Robert J Fontana; Jiezhun Gu; David E Kleiner; M James Lopez
Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Journal of pediatric gastroenterology and nutrition 2011;53(2):182-9.
2011: Haripriya Maddur; Saurabh Agrawal; Naga Chalasani; Nabil Fayad; Charles J Kahi
Acute cholecystitis after colonoscopy: a case series.
Gastrointestinal endoscopy 2011;74(1):211-3.
2011: Arun J Sanyal; Vlad Ratziu; Elizabeth M Brunt; Naga Chalasani; David E Kleiner; Kris V Kowdley; Joel Edward Lavine; Arthur McCullough
Endpoints and clinical trial design for nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2011;54(1):344-53.
2011: Suthat Liangpunsakul; Naga Chalasani
Serum vitamin D concentrations and unexplained elevation in ALT among US adults.
Digestive diseases and sciences 2011;56(7):2124-9.
2011: Kenneth Berman; Sweta Tandra; Raj Vuppalanch; Marwan Ghabril; Kumaresan Sandrasegaran; James Nguyen; Helena Caffrey; Suthat Liangpunsakul; Lawrence Lumeng; Paul Y Kwo; Raj Vuppalanchi; Naga Chalasani
Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study.
The American journal of gastroenterology 2011;106(5):899-906.
2011: Joel Edward Lavine; Jeffrey B Schwimmer; Mark L Van Natta; Jean P Molleston; Karen F Murray; Philip Rosenthal; Stephanie H Abrams; ANN SCHEIMANN; Arun J Sanyal; Naga Chalasani; James Tonascia; Aynur Unalp; Jeanne M Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
JAMA : the journal of the American Medical Association 2011;305(16):1659-68.
2011: Allison M Fullenkamp; Lauren N Bell; Reiesha D Robbins; Lydia Lee; Romil Saxena; Mouhamad Alloosh; James E Klaunig; Raghavendra G Mirmira; Michael Sturek; Naga Chalasani
Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine.
Pancreas 2011;40(3):438-43.
2011: Kenneth Berman; Sweta Tandra; Kate Forssell; Raj Vuppalanch; James R Burton; James Nguyen; Devonne Mullis; Paul Y Kwo; Raj Vuppalanchi; Naga Chalasani
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(3):254-9.
2011: Klara Werling; Naga Chalasani
What is the Role of Midodrine in Patients with Decompensated Cirrhosis?
Gastroenterology & hepatology 2011;7(2):134-6.
2011: Haripriya Maddur; Naga Chalasani
Idiosyncratic drug-induced liver injury: a clinical update.
Current gastroenterology reports 2011;13(1):65-71.
2011: Ravi Juluri; Raj Vuppalanchi; John Olson; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; James Tonascia; Naga Chalasani
Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.
Journal of clinical gastroenterology 2011;45(1):55-8.
2010: Patrick R Kenny; Daniel E Brady; Dawn M Torres; Linda Ragozzino; Naga Chalasani; Stephen A Harrison
Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series.
The American journal of gastroenterology 2010;105(12):2707-9.
2010: Douglas K Rex; David Hewett; Meghana Raghavendra; Naga Chalasani
The impact of videorecording on the quality of colonoscopy performance: a pilot study.
The American journal of gastroenterology 2010;105(11):2312-7.
2010: Raj Vuppalanchi; P H Hayashi; Naga Chalasani; Robert J Fontana; H Bonkovsky; R Saxena; D Kleiner; J H Hoofnagle
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
Alimentary pharmacology & therapeutics 2010;32(9):1174-83.
2010: Naga Chalasani; Xiuqing Guo; Rohit Loomba; Mark O Goodarzi; Talin Haritunians; Soonil Kwon; Jinrui Cui; Kent D Taylor; Laura Wilson; Oscar W Cummings; Yii-Der Ida Chen; Jerome I Rotter
Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.
Gastroenterology 2010;139(5):1567-76, 1576.e1-6.
2010: V L Misra; Raj Vuppalanchi; D Jones; Mitchell A Hamman; Paul Y Kwo; Charles J Kahi; Naga Chalasani
The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.
Alimentary pharmacology & therapeutics 2010;32(8):1044-50.
2010: Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel Edward Lavine; Naga Chalasani; Kris V Kowdley
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2010;52(3):913-24.
2010: Jaideep Behari; Naga Chalasani
Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis.
The American journal of pathology 2010;177(1):10-2.
2010: Don C Rockey; Leonard B Seeff; James Rochon; James Freston; Naga Chalasani; Maurizio Bonacini; Robert J Fontana; Paul H Hayashi
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
Hepatology (Baltimore, Md.) 2010;51(6):2117-26.
2010: Lauren N Bell; Constance J Temm; Rashmil Saxena; Raj Vuppalanchi; Philip Schauer; Mordechai Rabinovitz; Alyssa Krasinskas; Naga Chalasani; Samer G Mattar
Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.
Annals of surgery 2010;251(6):1041-8.
2010: Naga Chalasani; Einar Björnsson
Risk factors for idiosyncratic drug-induced liver injury.
Gastroenterology 2010;138(7):2246-59.
2010: Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel Edward Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne M Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
The New England journal of medicine 2010;362(18):1675-85.
2010: Marwan Ghabril; Naga Chalasani; Einar Björnsson
Drug-induced liver injury: a clinical update.
Current opinion in gastroenterology 2010;26(3):222-6.
2010: Lauren N Bell; Lydia Lee; Romil Saxena; Kerry G Bemis; Mu Wang; Janice L Theodorakis; Raj Vuppalanchi; Mouhamad Alloosh; Michael Sturek; Naga Chalasani
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
American journal of physiology. Gastrointestinal and liver physiology 2010;298(5):G746-54.
2010: Craig Lammert; Einar Bjornsson; Anna Niklasson; Naga Chalasani
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events.
Hepatology (Baltimore, Md.) 2010;51(2):615-20.
2010: Lauren N Bell; Janice L Theodorakis; Raj Vuppalanchi; Romil Saxena; Kerry G Bemis; Mu Wang; Naga Chalasani
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2010;51(1):111-20.
2009: Anand Dutta; Chandan Saha; Cynthia S Johnson; Naga Chalasani
Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study.
Hepatology (Baltimore, Md.) 2009;50(6):1957-62.
2009: Lauren N Bell; Naga Chalasani
Epidemiology of idiosyncratic drug-induced liver injury.
Seminars in liver disease 2009;29(4):337-47.
2009: Naga Chalasani
Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!
Gastroenterology 2009;137(3):772-5.
2009: Lydia Lee; Mouhamad Alloosh; Romil Saxena; William Van Alstine; Bruce A Watkins; James Klaunig; Michael Sturek; Naga Chalasani
Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Hepatology (Baltimore, Md.) 2009;50(1):56-67.
2009: Timothy J Davern; Naga Chalasani
Drug-induced liver injury in clinical trials: as rare as hens' teeth.
The American journal of gastroenterology 2009;104(5):1159-61.
2009: Raj Vuppalanchi; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; Kumar E Sandrasegaran; Tariq Hameed; James Tonascia; Naga Chalasani
Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(4):481-6.
2009: John Dewitt; Kathleen McGreevy; Oscar Cummings; Stuart Sherman; Julia K Leblanc; Lee McHenry; Mohammad Al-Haddad; Naga Chalasani
Initial experience with EUS-guided Tru-cut biopsy of benign liver disease.
Gastrointestinal endoscopy 2009;69(3 Pt 1):535-42.
2009: Vijay Laxmi Misra; Mouen Khashab; Naga Chalasani
Nonalcoholic fatty liver disease and cardiovascular risk.
Current gastroenterology reports 2009;11(1):50-5.
2009: Robert J Fontana; Paul B Watkins; Herbert L Bonkovsky; Naga Chalasani; Timothy Davern; Jose Serrano; James Rochon
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(1):55-68.
2009: Raj Vuppalanchi; Naga Chalasani
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.
Hepatology (Baltimore, Md.) 2009;49(1):306-17.
2009: Margaret S Sozio; Naga Chalasani; Suthat Liangpunsakul
What advice should be given to patients with NAFLD about the consumption of alcohol?
Nature clinical practice. Gastroenterology & hepatology 2009;6(1):18-9.
2008: David Gulley; Evgenia Teal; Attaya Suvannasankha; Naga Chalasani; Suthat Liangpunsakul
Deep vein thrombosis and pulmonary embolism in cirrhosis patients.
Digestive diseases and sciences 2008;53(11):3012-7.
2008: S R Malireddy; Amar G Pinto; Naga Chalasani; Gorski Jan; Stephen D Hall
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report.
Transplantation proceedings 2008;40(5):1789-91.
2008: Vijay L Misra; Naga Chalasani
Obstructive sleep apnea and nonalcoholic fatty liver disease: causal association or just a coincidence?
Gastroenterology 2008;134(7):2178-9.
2008: Craig Lammert; Stefan Einarsson; Chandan Saha; Anna Niklasson; Einar Bjornsson; Naga Chalasani
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
Hepatology (Baltimore, Md.) 2008;47(6):2003-9.
2008: Naga Chalasani; Laura Wilson; David E Kleiner; Oscar W Cummings; Elizabeth M Brunt; Aynur Unalp
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.
Journal of hepatology 2008;48(5):829-34.
2008: Mouen Khashab; Suthat Liangpunsakul; Naga Chalasani
Nonalcoholic fatty liver disease as a component of the metabolic syndrome.
Current gastroenterology reports 2008;10(1):73-80.
2008: Mazen Alsatie; Prashant Pandya; Naga Chalasani
Insulin resistance, hepatitis C, and liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(2):136-7.
2008: Michael Charlton; Paul Angulo; Naga Chalasani; Ralph Merriman; Kimberly Viker; Phunchai Charatcharoenwitthaya; Schuyler Sanderson; Samer Gawrieh; Anuradha Krishnan; Keith D Lindor
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2008;47(2):484-92.
2007: Mouen Khashab; Naga Chalasani
Use of insulin sensitizers in NASH.
Endocrinology and metabolism clinics of North America 2007;36(4):1067-87; xi.
2007: Spencer Wilson; Naga Chalasani
Noninvasive markers of advanced histology in nonalcoholic fatty liver disease: are we there yet?
Gastroenterology 2007;133(4):1377-8; discussion 1378-9.
2007: James E Nelson; Renuka Bhattacharya; Keith D Lindor; Naga Chalasani; Stuart Raaka; E Jenny Heathcote; Emil Miskovsky; Eldon Shaffer; Stephen J Rulyak; Kris V Kowdley
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2007;46(3):723-9.
2007: Sidharth S Bhardwaj; Naga Chalasani
Lipid-lowering agents that cause drug-induced hepatotoxicity.
Clinics in liver disease 2007;11(3):597-613, vii.
2007: Suthat Liangpunsakul; Naga Chalasani
Metabolic syndrome following liver transplantation is associated with major vascular events.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(8):1078-9.
2007: H Shen; D Agarwal; R Qi; Naga Chalasani; Suthat Liangpunsakul; L Lumeng; H Yoo; Paul Y Kwo
Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
Alimentary pharmacology & therapeutics 2007;26(3):393-400.
2007: James R Burton; Suthat Liangpunsakul; Jodi A Lapidus; Edoardo Giannini; Naga Chalasani; Atif Zaman
Validation of a multivariate model predicting presence and size of varices.
Journal of clinical gastroenterology 2007;41(6):609-15.
2007: Naga Chalasani; Chandan Saha; Evgenia Y Teal
Are there ethnicity-based differences in the evaluation of individuals with abnormal liver biochemistries?
Journal of hepatology 2007;47(1):123-7.
2007: A James Hanje; Naga Chalasani
How common is chronic liver disease from acute drug-induced liver injury?
Gastroenterology 2007;132(5):2067-8; discussion 2068-9.
2007: Tuesday Werner; Hugo E Vargas; Naga Chalasani
Macro-aspartate aminotransferase and monoclonal gammopathy: a review of two cases.
Digestive diseases and sciences 2007;52(5):1197-8.
2007: Raj Vuppalanchi; Naga Chalasani
Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant?
Gastroenterology 2007;132(4):1624-6.
2007: Thomas F Imperiale; Robert W Klein; Naga Chalasani
Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.
Hepatology (Baltimore, Md.) 2007;45(4):870-8.
2007: Dhanashri Kolwankar; Raj Vuppalanchi; Brian Ethell; David R Jones; Steven A Wrighton; Stephen D Hall; Naga Chalasani
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(3):388-93.
2007: Raj Vuppalanchi; Suthat Liangpunsakul; Naga Chalasani
Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?
The American journal of gastroenterology 2007;102(3):558-62; quiz 693.
2007: Raj Vuppalanchi; Oscar W Cummings; Romil Saxena; Thomas M Ulbright; Nikhil Martis; David R Jones; Navin Bansal; Naga Chalasani
Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples.
Journal of clinical gastroenterology 2007;41(2):206-10.
2007: Jonathan A Fridell; Romil Saxena; Naga Chalasani; William C Goggins; John A Powelson; Oscar W Cummings
Complete reversal of glycogen hepatopathy with pancreas transplantation: two cases.
Transplantation 2007;83(1):84-6.
2007: Mazen Alsatie; Naga Chalasani; Paul Y Kwo
Management of hepatitis C infection after liver transplantation.
Drugs 2007;67(6):871-85.
2006: Raj Vuppalanchi; Naga Chalasani; Romil Saxena
Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
The American journal of surgical pathology 2006;30(12):1619-23.
2006: Vamsee Alla; Joseph Abraham; Junaid Siddiqui; Dimple Raina; George Y Wu; Naga Chalasani; Herbert L Bonkovsky
Autoimmune hepatitis triggered by statins.
Journal of clinical gastroenterology 2006;40(8):757-61.
2006: Raj Vuppalanchi; Naga Chalasani
Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices.
Gastroenterology 2006;131(2):674-6; discussion 676.
2006: Raj Vuppalanchi; Naga Chalasani
Statins for hyperlipidemia in patients with chronic liver disease: are they safe?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(7):838-9.
2006: Joel R Lim; Philip R Faught; Naga Chalasani; Jean P Molleston
Severe liver injury after initiating therapy with atomoxetine in two children.
The Journal of pediatrics 2006;148(6):831-4.
2006: Naga Chalasani; Raj Vuppalanchi; Nandita S Raikwar; Mark A Deeg
Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
The Journal of clinical endocrinology and metabolism 2006;91(6):2279-85.
2006: David E Cohen; Frank A Anania; Naga Chalasani
An assessment of statin safety by hepatologists.
The American journal of cardiology 2006;97(8A):77C-81C.
2005: Atif Zaman; Naga Chalasani
Bleeding caused by portal hypertension.
Gastroenterology clinics of North America 2005;34(4):623-42.
2005: Naga Chalasani; Evgenia Y Teal; Stephen D Hall
Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.
The American journal of gastroenterology 2005;100(6):1317-21.
2005: Suthat Liangpunsakul; Dhanashri Kolwankar; Amar Pinto; Gorski Jan; Stephen D Hall; Naga Chalasani
Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
Hepatology (Baltimore, Md.) 2005;41(5):1144-50.
2005: Amar G Pinto; JC Horlander; Naga Chalasani; Mitchell A Hamman; Ali Asghar; Dhanashri Kolwankar; Stephen D Hall
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.
British journal of clinical pharmacology 2005;59(4):440-6.
2005: Naga Chalasani
Statins and hepatotoxicity: focus on patients with fatty liver.
Hepatology (Baltimore, Md.) 2005;41(4):690-5.
2005: Naga Chalasani; Thomas D Boyer
Primary prophylaxis against variceal bleeding: beta-blockers, endoscopic ligation, or both?
The American journal of gastroenterology 2005;100(4):805-7.
2005: Suthat Liangpunsakul; Naga Chalasani
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).
The American journal of the medical sciences 2005;329(3):111-6.
2005: Viju P Deenadayalu; Ernest J Orinion; Naga Chalasani; Hwan Y Yoo
Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(3):xxix.
2005: Amar G Pinto; Ying-Hong Wang; Naga Chalasani; Todd C Skaar; Dhanashri Kolwankar; Gorski Jan; Suthat Liangpunsakul; Mitchell A Hamman; Million Arefayene; Stephen D Hall
Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
Clinical pharmacology and therapeutics 2005;77(3):178-88.
2005: Adegboyega Q Adigun; Amar G Pinto; David A Flockhart; Gorski Jan; Lang Li; Stephen D Hall; Naga Chalasani
Effect of cirrhosis and liver transplantation on the gender difference in QT interval.
The American journal of cardiology 2005;95(5):691-4.
2005: Raj Vuppalanchi; Smitha Marri; Dhanashri Kolwankar; Robert V Considine; Naga Chalasani
Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.
Journal of clinical gastroenterology 2005;39(3):237-42.
2005: Raj Vuppalanchi; Evgenia Y Teal; Naga Chalasani
Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.
The American journal of the medical sciences 2005;329(2):62-5.
2005: Naga Chalasani; Cosme Manzarbeitia; Peter Ferenci; Wolfgang Vogel; Robert J Fontana; Michael Voigt; Caroline Riely; Paul Martin; Lewis W Teperman; James Jiao; Juan Carlos Lopez-Talavera
Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials.
Hepatology (Baltimore, Md.) 2005;41(2):289-98.
2005: Suthat Liangpunsakul; Naga Chalasani
Relationship between hepatitis C and microalbuminuria: results from the NHANES III.
Kidney international 2005;67(1):285-90.
2004: Suthat Liangpunsakul; Naga Chalasani
Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III).
Journal of clinical gastroenterology 2004;38(10):891-7.
2004: Paul Haynes; Suthat Liangpunsakul; Naga Chalasani
Nonalcoholic fatty liver disease in individuals with severe obesity.
Clinics in liver disease 2004;8(3):535-47, viii.
2004: Naga Chalasani; Mark A Deeg; David W Crabb
Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
The American journal of gastroenterology 2004;99(8):1497-502.
2004: William R Kessler; Oscar W Cummings; George Eckert; Naga Chalasani; Lawrence Lumeng; Paul Y Kwo
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(7):625-31.
2004: Naga Chalasani; Hisham Aljadhey; Joseph Kesterson; Michael D Murray; Stephen D Hall
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.
Gastroenterology 2004;126(5):1287-92.
2004: Hong Shen; Mazen Alsatie; George Eckert; Naga Chalasani; Lawrence Lumeng; Paul Y Kwo
Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(4):330-6.
2004: A Joseph Tector; Jonathan A Fridell; Richard S Mangus; Ashesh Shah; Martin L Milgrom; Paul Y Kwo; Naga Chalasani; Hwan Yoo; Dale Rouch; Suthat Liangpunsakul; Scott Herring; Lawrence Lumeng
Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(3):404-7.
2003: Suthat Liangpunsakul; D Agarwal; JC Horlander; B Kieff; Naga Chalasani
Positron emission tomography for detecting occult hepatocellular carcinoma in hepatitis C cirrhotics awaiting for liver transplantation.
Transplantation proceedings 2003;35(8):2995-7.
2003: Naga Chalasani; David W Crabb; Oscar W Cummings; Paul Y Kwo; Ali Asghar; Prashant Pandya; Robert V Considine
Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
The American journal of gastroenterology 2003;98(12):2771-6.
2003: Thomas F Imperiale; Naga Chalasani; Robert W Klein
Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
The American journal of gastroenterology 2003;98(12):2742-50.
2003: Brian R Weston; Vidyasree Chadalawada; Naga Chalasani; Paul Y Kwo; Christine A Overley; Michelle Symms; Eloise Strahl; Douglas K Rex
Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients.
The American journal of gastroenterology 2003;98(11):2440-7.
2003: Suthat Liangpunsakul; Naga Chalasani
Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?
Journal of clinical gastroenterology 2003;37(4):340-3.
2003: Suthat Liangpunsakul; Brian J Ulmer; Naga Chalasani
Predictors and implications of severe hypersplenism in patients with cirrhosis.
The American journal of the medical sciences 2003;326(3):111-6.
2003: Naga Chalasani; Mark A Deeg; Scott Persohn; David W Crabb
Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
The American journal of gastroenterology 2003;98(8):1849-55.
2003: Naga Chalasani; Charles Kahi; Fritz Francois; Amar Pinto; Atul Marathe; Edmund J Bini; Prashant Pandya; Shanthi V Sitaraman; Jianzhao Shen
Improved patient survival after acute variceal bleeding: a multicenter, cohort study.
The American journal of gastroenterology 2003;98(3):653-9.
2003: Naga Chalasani; Gorski Jan; Maleeha S Asghar; Ali Asghar; Brian H Foresman; Stephen D Hall; David W Crabb
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2003;37(3):544-50.
2002: Amar G Pinto; Oscar W Cummings; Naga Chalasani
Severe but reversible cholestatic liver injury after pioglitazone therapy.
Annals of internal medicine 2002;137(10):857.
2002: Lennox Jeffers; Naga Chalasani; Luis Balart; Nikolaos Pyrsopoulos; Elisabeth Erhardtsen
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy.
Gastroenterology 2002;123(1):118-26.
2002: Sujatha Sampathkumar; Cheryl Younger; Harvey Cramer; Naga Chalasani; Paul A Skierczynski
Langerhans' cell histiocytosis involving the pituitary, thyroid, lung, and liver.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2002;8(3):217-21.
2002: Naga Chalasani; Charles Kahi; Fritz Francois; Amar Pinto; Atul Marathe; Edmund J Bini; Prashant Pandya; Shanthi V Sitaraman; Jianzhao Shen
Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding.
Hepatology (Baltimore, Md.) 2002;35(5):1282-4.
2002: Rungsun Rerknimitr; Stuart Sherman; Evan L Fogel; Cem Kalayci; Lawrence Lumeng; Naga Chalasani; Paul Y Kwo; Glen A Lehman
Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy.
Gastrointestinal endoscopy 2002;55(2):224-31.
2001: Naga Chalasani; Gorski Jan; Nilesh H Patel; Stephen D Hall; Raymond E Galinsky
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
Hepatology (Baltimore, Md.) 2001;34(6):1103-8.
2001: Nilesh H Patel; K J Sasadeusz; R Seshadri; Naga Chalasani; Himanshu Shah; Matthew S Johnson; Jan Namyslowski; Kenneth P Moresco; Scott O Trerotola
Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality.
Journal of vascular and interventional radiology : JVIR 2001;12(11):1279-84.
2001: RM Ness; R Manam; H Hoen; Naga Chalasani
Predictors of inadequate bowel preparation for colonoscopy.
The American journal of gastroenterology 2001;96(6):1797-802.
2001: Naga Chalasani; Gorski Jan; JC Horlander; R Craven; H Hoen; Juan F Maya; D Craig Brater
Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.
Journal of the American Society of Nephrology : JASN 2001;12(5):1010-6.
2001: Thomas F Imperiale; Naga Chalasani
A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding.
Hepatology (Baltimore, Md.) 2001;33(4):802-7.
2001: A R Baluyut; Stuart Sherman; Glen A Lehman; H Hoen; Naga Chalasani
Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.
Gastrointestinal endoscopy 2001;53(3):308-12.
2001: D Craig Brater; Naga Chalasani; Gorski Jan; JC Horlander; R Craven; H Hoen; Juan F Maya
Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
Transactions of the American Clinical and Climatological Association 2001;112():108-15; discussion 116.
2000: Naga Chalasani; A Baluyut; A Ismail; Atif Zaman; G Sood; R Ghalib; T M McCashland; K R Reddy; X Zervos; M A Anbari; H Hoen
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Hepatology (Baltimore, Md.) 2000;31(1):7-11.
2000: Naga Chalasani; W S Clark; L G Martin; J Kamean; M A Khan; Nilesh H Patel; T D Boyer
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting.
Gastroenterology 2000;118(1):138-44.
1999: Naga Chalasani; Thomas F Imperiale; A Ismail; G Sood; M Carey; C M Wilcox; H Madichetty; Paul Y Kwo; T D Boyer
Predictors of large esophageal varices in patients with cirrhosis.
The American journal of gastroenterology 1999;94(11):3285-91.
1999: JC Horlander; N Boyle; R Manam; M Schenk; S Herring; Paul Y Kwo; L Lumeng; Naga Chalasani
Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation.
The American journal of the medical sciences 1999;318(5):304-7.
1999: Naga Chalasani; JC Horlander; AT Said; H Hoen; Kenyon K Kopecky; SM Stockberger; R Manam; Paul Y Kwo; L Lumeng
Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
The American journal of gastroenterology 1999;94(10):2988-93.
1999: Naga Chalasani; AT Said; RM Ness; H Hoen; L Lumeng
Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
The American journal of gastroenterology 1999;94(8):2224-9.
1999: Naga Chalasani; C M Wilcox
Gastrointestinal hemorrhage in patients with AIDS.
AIDS patient care and STDs 1999;13(6):343-6.
1998: Nilesh H Patel; Naga Chalasani; Rahul M Jindal
Current status of transjugular intrahepatic portosystemic shunts.
Postgraduate medical journal 1998;74(878):716-20.
1998: Naga Chalasani; N Gitlin
Acute hepatitis A: what's new with it?
The American journal of gastroenterology 1998;93(11):2305-6.
1998: Naga Chalasani; N Gitlin
Role of hepatic iron index in the management of iron overload syndromes in 1990's.
The American journal of gastroenterology 1998;93(8):1385-6.
1998: Naga Chalasani; K Patel; WS Clark; CM Wilcox
The prevalence and significance of leukocytosis in upper gastrointestinal bleeding.
The American journal of the medical sciences 1998;315(4):233-6.
1998: Naga Chalasani; G Smallwood
Idiopathic ulcerative colitis in patients with primary sclerosing colitis undergoing orthotopic liver transplantation (OLT)
The American journal of gastroenterology 1998;93(3):481-2.
1998: Naga Chalasani; Gregory A Smallwood; J Halcomb; Michael W Fried; T D Boyer
Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation?
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1998;4(2):128-32.
1998: Naga Chalasani; CM Wilcox
Etiology and outcome of lower gastrointestinal bleeding in patients with AIDS.
The American journal of gastroenterology 1998;93(2):175-8.
1998: Naga Chalasani; John M Wo; J Patrick Waring
Racial differences in the histology, location, and risk factors of esophageal cancer.
Journal of clinical gastroenterology 1998;26(1):11-3.
1997: Naga Chalasani; N Gitlin
Why do we need a newer generation of recombinant vaccines against hepatitis B?
The American journal of gastroenterology 1997;92(12):2314-5.
1997: Naga Chalasani; N Gitlin
TIPS for patients with refractory hepatic hydrothorax: what is the take-home message?
The American journal of gastroenterology 1997;92(11):2129-30.
1997: Naga Chalasani; WS Clark; CM Wilcox
Blood urea nitrogen to creatinine concentration in gastrointestinal bleeding: a reappraisal.
The American journal of gastroenterology 1997;92(10):1796-9.
1997: Naga Chalasani; N Gitlin
Thrombocytopenia associated with hepatitis C: is it real?
The American journal of gastroenterology 1997;92(7):1234-5.
1997: Naga Chalasani; A J Lazenby; C M Wilcox
Unusual endoscopic features of gastric and duodenal cryptosporidiosis in AIDS.
Gastrointestinal endoscopy 1997;45(6):525-7.
1997: Naga Chalasani; Namita Roy-Chowdhury; Jayanta Roy-Chowdhury; Thomas D Boyer
Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect.
Gastroenterology 1997;112(6):2099-103.
1997: Naga Chalasani; C C Nguyen; N Gitlin
Spontaneous rupture of a bile duct and its endoscopic management in a patient with Caroli's syndrome.
The American journal of gastroenterology 1997;92(6):1062-3.
1997: Naga Chalasani; N Gitlin
Subclinical hepatic encephalopathy: how best to diagnose?
The American journal of gastroenterology 1997;92(5):905-6.
1997: Naga Chalasani; K Parker; C M Wilcox
Barrett's adenocarcinoma in a patient with acquired immune deficiency syndrome.
Journal of clinical gastroenterology 1997;24(3):184-6.
1997: Naga Chalasani; C M Wilcox; H T Hunter; D A Schwartz
Endoscopic features of gastroduodenal cryptococcosis in AIDS.
Gastrointestinal endoscopy 1997;45(3):315-7.
1997: Naga Chalasani; John M Wo; John G Hunter; J Patrick Waring
Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction.
Digestive diseases and sciences 1997;42(3):603-7.
1996: Naga Chalasani; George Cotsonis; CM Wilcox
Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia.
The American journal of gastroenterology 1996;91(11):2329-32.
1996: Naga Chalasani; N Gitlin
Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
The American journal of gastroenterology 1996;91(6):1266-8.
1996: Naga Chalasani; J Roman; R L Jurado
Systemic inflammatory response syndrome caused by chronic salicylate intoxication.
Southern medical journal 1996;89(5):479-82.
1996: Naga Chalasani; C M Wilcox
Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome.
Hepatology (Baltimore, Md.) 1996;23(4):728-33.
1995: Naga Chalasani; M A Valdecanas; A K Gopal; John E McGowan; R L Jurado
Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks.
Chest 1995;108(4):932-6.